{
  "docId": "019de073-98a7-740c-b2bf-3eb3f25491f5",
  "docSlug": "adb5c4514a6016378ffb63c7d4422971",
  "documentTitle": "TCR2 Therapeutics | Results Presentation Deck | 34 slides",
  "authorId": "tcr2-therapeutics",
  "authorName": "TCR2 Therapeutics",
  "documentKindSlug": "regulatory-filing",
  "documentKindLabel": "Regulatory filing",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 34,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "The slide uses a comparative structure to frame gavo-cel as a superior therapeutic option compared to historical anti-mesothelin CAR-T approaches.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-98a7-740c-b2bf-3eb3f25491f5/7",
  "deckHref": "/decks/019de073-98a7-740c-b2bf-3eb3f25491f5",
  "deckJsonHref": "/decks/019de073-98a7-740c-b2bf-3eb3f25491f5.json",
  "deckAnchorHref": "/decks/019de073-98a7-740c-b2bf-3eb3f25491f5#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.348,
        "y": 0.415
      },
      "kind": "list",
      "text": "Total RECIST Responses reported",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2ff199fc-d05f-480a-ac4b-bef442d4a803",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.348,
        "y": 0.265
      },
      "kind": "list",
      "text": "Patients treated with anti-mesothelin CAR-T monotherapy",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "475918f4-0a8d-4764-b575-92672a5e62f3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.348,
        "y": 0.625
      },
      "kind": "list",
      "text": "Patients evaluable treated with gavo-cel (TRuC-T cell) monotherapy",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a3c836a-09c4-460e-8fe1-3b217e38ca7d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.348,
        "y": 0.775
      },
      "kind": "list",
      "text": "Total RECIST Responses reported",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ce1bd825-9350-4d29-bd27-245088c2a857",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.04,
        "x": 0.268,
        "y": 0.258
      },
      "kind": "metric",
      "text": "74",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "068f5655-3ba4-48e2-862c-0241ba78fe72",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.04,
        "x": 0.268,
        "y": 0.755
      },
      "kind": "metric",
      "text": "6",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0f6061d9-95aa-4a59-9865-267cc32fb496",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.04,
        "x": 0.268,
        "y": 0.395
      },
      "kind": "metric",
      "text": "1",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1691a7f8-7f1f-4739-821c-15f70474ef8f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.04,
        "x": 0.268,
        "y": 0.62
      },
      "kind": "metric",
      "text": "30",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ce5a1658-504e-492a-90fa-3ac336705500",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.08,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Maus et al., 2013, Cancer Immunol. Res.; Beatty et al., 2014, Cancer Immunol. Res.; Hass et al., 2019, Mol. Therapy.; www.med.upenn.edu/cellicon2021/assets/user-content/documents/tanyi.pdf; Adusumilli et al., 2021, Cancer Discovery; Wang et al., 2021, Cell Mol. Immunol.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c17b9a3-9667-4233-83b0-3bd41dd84c9a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "First Anti-Mesothelin Cell Therapy to Demonstrate Tolerability and Clinical Benefit",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dd3f6f8e-ae1b-49c8-ba98-04f23306dd26",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Clinically, gavo-cel Has Shown Activity Where Others Have Failed",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d622621c-7326-4984-8c95-037dedc8fa67",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "a2868537-90e1-46c0-a9ae-1d2271f566d1",
      "evidence": "The slide explicitly compares two cohorts (CAR-T vs gavo-cel) to demonstrate superior clinical outcomes.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 7,
      "from": 5,
      "beatId": "fdf73b00-7260-487c-b13a-7107eda1fd89",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "The document highlights the limitations and challenges of current TCR-T and CAR-T therapies.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 7,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "6c44a701-b661-4c85-8bea-fc00b1744576",
      "evidence": "The document highlights the limitations and challenges of current therapies.",
      "position": 0,
      "objective": "What are the consequences of not improving treatment options for solid tumors?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}